Drugdiscovery >> Drugs >> News
6270
Views
Zerenex, a promising drug for treating chronic kidney disease - drugdiscovery.com
Zerenex, a promising drug for treating chronic kidney disease - drugdiscovery.com


Keryx Biopharmaceuticals has submitted a New Drug Application to the FDA. The drug is iron-based phosphate binder Zerenex, which showed impressive results in a phase III trial in treating elevated serum phosphate levels in patients with chronic kidney disease, on dialysis.
Read More >>


Tags: Keryx Biopharmaceuticals, Zerenex, chronic kidney disease - August 12, 2013
Related Articles
4124
Views
Triferic - a trade name of Rockwell Medical's chronic kidney disease drug Triferic - a trade name of Rockwell Medical's chronic kidney disease drug
The FDA has accepted the proposed proprietary trade name for the Rockwell Medical's soluble ferric pyrophosphate (SFP), an investigational iron-delivery drug intended for treating iron deficiency in Read More >>

Tags: Triferic, chronic kidney disease, iron deficiency, new drug, Rockwell Medical, soluble ferric pyrophosphate

3589
Views
No recommendation for tolvaptan for treatment of ADPKD in US No recommendation for tolvaptan for treatment of ADPKD in US
The FDA’s advisory committee decided not to recommend Otsuka’s drug tolvaptan for the indication of slowing kidney disease in adults at risk for rapidly progressing autosomal dominant polycystic Read More >>

Tags: Otsuka,tolvaptan, kidney disease, rapidly progressing autosomal dominant polycystic kidney disease, kidney, polycystic

4717
Views
Vedolizumab shows promise in treating severe inflammatory bowel disease Vedolizumab shows promise in treating severe inflammatory bowel disease
The results of two separate studies show that Vedolizumab, a humanized monoclonal antibody that selectively blocks gut lymphocyte trafficking, is effective as induction and maintenance therapy for ul Read More >>

Tags: ulcerative colitis, Crohn’s disease, clinical trial, vedolizumab, inflamatory bowel disease

3851
Views
Orlistat might cause kidney stones Orlistat might cause kidney stones
The results of an animal study suggest that one of the side effects of an anti-obesity drug orlistat might be the increased risk of kidney stones. Read More >>

Tags: orlistat, anti-obesity drug, risk, side effects, kidney stones, animal study

4608
Views
Risedronate shows promise in treating brittle bone disease in children Risedronate shows promise in treating brittle bone disease in children
The results of phase III clinical trial have showed that risedronate, previously used to treat osteoporosis in adults, significantly reduces the risk of clinical fracture in children with osteogenesi Read More >>

Tags: osteogenesis imperfecta, brittle bone disease, risedonate, treatment

3177
Views
New Chronic Blood Cancer drug on the market New Chronic Blood Cancer drug on the market
The new drug of Global Blood Therapeutics is goning to be a godsend for patients of sickle cell disease. The oral treatment prevents sickling of blood cells. Read More >>

Tags: sickle cell disease, blood cell, Global Blood Therapeutics,

2665
Views
New diabetes drug, Forxiga was apporved by FDA New diabetes drug, Forxiga was apporved by FDA
Astra Zeneca's new anti-diabetes drug, Forxiga was approved by US Food and Durg Administration. This is a sodium-glucose co-transporter, which blocks the reabsorption of glucose by the kidney. Read More >>

Tags: kidney, reabsortion, glucose, Forxiga, AstraZeneca

11892
Views
New drug for treating myeloma approved in Europe New drug for treating myeloma approved in Europe
The European Commission has granted approval for Celgene’s drug pomalidomide for the treatment of relapsed and refractory multiple myeloma, in combination with dexamethasone. The marketing name of Read More >>

Tags: Celgene, pomalidomide, multiple myeloma,Imnovid,the European Commission approval

7122
Views
The most promising drugs in biopharma's  late-stage pipeline The most promising drugs in biopharma's late-stage pipeline
An expert’s opinion on which are the 10 most prospective drugs in the late-stage pipeline at this moment. Read More >>

Tags: top 10, most promising, drugs, prospective, biopharma, pipeline

6145
Views
Aflibercept cancer drug might have beneficial effect in treating diabetes Aflibercept cancer drug might have beneficial effect in treating diabetes
Researchers have identified a series of protein interactions that link VEGF inhibitors, such as Aflibercept, with blood glucose levels, explaining an earlier observation that VEGF inhibitors could lo Read More >>

Tags: Eylea, aflibercept, VEGF inhiibitor, cancer, drug, blood glucose levels, diabetes

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013